![INMED PHARMACEUTICALS INC](https://cdn.moneypeak.ai/logos/fallback/1.png)
CA4576376012 - INM (XTSE)
INMED PHARMACEUTICALS INC Share
6,62 CAD
Current Prices from INMED PHARMACEUTICALS INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
![]() NASDAQ |
INM
|
USD
|
27.12.2024 19:12
|
4,60 USD
| 4,59 USD | 0,22 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
3,64 % | 4,74 % | 7,24 % | 2.033,69 % | 1.737,22 % | 1.161,56 % | -96,86 % |
Company Profile for INMED PHARMACEUTICALS INC Share
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Company Data for INMED PHARMACEUTICALS INC Share
![INMED PHARMACEUTICALS INC](https://cdn.moneypeak.ai/logos/fallback/1.png)
Name INMED PHARMACEUTICALS INC
Company InMed Pharmaceuticals Inc.
Symbol INM
Website https://www.inmedpharma.com
Primary Exchange
TSX
ISIN CA4576376012
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Eric A. Adams B.S. Chem., M.I.B.
Country Canada
Currency CAD
Employees 0,0 T
Address 815 West Hastings Street, V6C 1B4 Vancouver
IPO Date 2014-05-05
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | MWG0.F |
NASDAQ | INM |
More Shares
Investors who INMED PHARMACEUTICALS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.